Moreover, metformin activates AMPK/p53 axis, to promote inhibition of melanoma metastasis, as well as induces down-regulation of NF-kB/STAT3 pathway, to inhibit melanoma-initiating cells (MIC) (130, 131, 137). The gene discussed is STAT3; the disease is melanoma.